首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Oncology Reports

Oncology Reports杂志,由Spandidos Publications出版,于1994年创刊,Monthly,出版语言English,ISSN:1021-335X,E-ISSN:1791-2431。

投稿咨询
Oncology Reports
Oncology Reports
Oncology Reports
SCI SCIE

杂志介绍

JCR分区
Q2
中科院分区
3区
影响因子
4.7
CiteScore
7.7
期刊收录
SCI、SCIE

Oncology Reports(中文译名:《肿瘤学报告》),ISSN:1021-335X,EISSN:1791-2431,是Spandidos Publications出版的国际性学术期刊,创刊于1994年,以Monthly形式稳定发行,2026年总发文量约118篇。该刊采用非OA开放访问,学科归属为医学 - 肿瘤学。该刊是医学、肿瘤学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达4.7,2025年期刊CiteScore为7.7,2025年期刊自引率约0%,在中科院期刊分区体系中位列医学大类3区,在所属学科领域具备高学术影响力与国际认可度。Oncology Reports长期聚焦医学、肿瘤学及相关产业的技术应用前沿,平均审稿周期约5.5月,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、肿瘤学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,CHINA MAINLANDJapan、USA、South Korea、Taiwan、Italy、GERMANY (FED REP GER)等为核心发文国家与地区;NANJING MEDICAL UNIVERSITYXI'AN JIAOTONG UNIVERSITY、JILIN UNIVERSITY、FUDAN UNIVERSITY、SHANDONG UNIVERSITY、SHANGHAI JIAO TONG UNIVERSITY、SUN YAT SEN UNIVERSITY等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
ONCOLOGY 肿瘤学
3区
否 否

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
ONCOLOGY 肿瘤学
4区
否 否

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
ONCOLOGY 肿瘤学
4区
否 否

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 97 / 333

71

学科:ONCOLOGY SCIE Q2 117 / 333

65.02

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 98 / 328

70.3

学科:ONCOLOGY SCIE Q2 108 / 328

67.23


中国学者近期发文

1
NF-κB-driven LUZP1 promotes metastasis and chemoresistance in head and neck squamous cell carcinom

Author:Lin, Chen-Yuan; Hsieh, Ching-Yun; Lan, Hsin-Chi; Lin, Ching-Chan; Chen, Tzu-Ting; Tseng, Wei-Chi; Tsou, Yung-An; Chang, Wei-Chao

Journal: ONCOLOGY REPORTS. 2026; Vol. 55, Issue 6, pp. -. DOI: 10.3892/or.2026.9115

2
T cell fate regulation in EBV-associated nasopharyngeal carcinoma (Review

Author:Zhang, Liuyang; Ding, Shun; Chen, Dongzhui; Cai, Benchi; Mu, Zhonglin

Journal: ONCOLOGY REPORTS. 2026; Vol. 55, Issue 6, pp. -. DOI: 10.3892/or.2026.9111

3
HMGB3: A pivotal orchestrator of therapy resistance and cancer stemness in human malignancies (Review

Author:Zhang, Ju; Sun, Yifan; Wang, Lanyu; Gu, Jiayu; Hua, Ye; Shao, Jianfeng; Feng, Ninghan

Journal: ONCOLOGY REPORTS. 2026; Vol. 55, Issue 6, pp. -. DOI: 10.3892/or.2026.9109

4
Role of CHD4 in tumor progression, DNA damage response and treatment resistance (Review

Author:Li, Shuo; Ma, Quan; Lian, Keying; Jiang, Zhisheng; Ma, Yun

Journal: ONCOLOGY REPORTS. 2026; Vol. 55, Issue 6, pp. -. DOI: 10.3892/or.2026.9112

5
Mechanistic study of MUC3A in promoting progression of clear cell renal cell carcinoma via the JAK-STAT pathwa

Author:Yun, Yongyang; Ji, Xing; Hu, Shuai; Wu, Tianyu; Liu, Yixiao; Li, Zheng; Sun, Zhoujie; Zhou, Peimin; Yang, Lei; Yu, Wei

Journal: ONCOLOGY REPORTS. 2026; Vol. 55, Issue 6, pp. -. DOI: 10.3892/or.2026.9119

6
PINK1-mediated mitophagy enhances breast cancer proliferation through metabolic reprogrammin

Author:Guo, Zong Jin; Yu, Qian; Sha, Rui; Li, Wei; Dai, Hui Juan

Journal: ONCOLOGY REPORTS. 2026; Vol. 55, Issue 6, pp. -. DOI: 10.3892/or.2026.9117

7
Unveiling the role of ANGPT2 in esophageal cancer: A prognostic factor and potential oncogen

Author:Zhai, Zhigang; Xue, Zhenyu; Fang, Yuan; Fan, Yixu; Li, Shijiao; Yu, Yunpeng; Chen, Chuansheng; Zhang, Kaijun; Chen, Deyu; Tang, Xiang; Ling, Rui

Journal: ONCOLOGY REPORTS. 2026; Vol. 55, Issue 5, pp. -. DOI: 10.3892/or.2026.9098

8
Silencing of SIVA-1 promotes cisplatin resistance in gastric cancer via the Bcl-2/BAX-mediated mitochondria-dependent apoptosis pathwa

Author:Shi, Zheng-Yi; Ding, Zheng-Rong; Huang, Yu-Liang; Lei, Yuan-Rui; Huang, Hai-Bin; Qing, Yan; Deng, Miao-Ren; Lu, Xu-Man; Dong, Xu-Dong; Xia, Long-Jie; Xu, Sheng; Zhong, Xiao-Gang; Li, Lei; Kong, Fan-Biao; Wang, Xiao-Tong

Journal: ONCOLOGY REPORTS. 2026; Vol. 55, Issue 5, pp. -. DOI: 10.3892/or.2026.9100

9
MS4322 is a selective protein arginine methyltransferase 5 degrader with antitumor effects in cervical cancer cell

Author:Luo, Rui; Chen, Jingping; Chen, Zhaojie; Wang, Surong; Liu, Tianfeng; Xu, Yang

Journal: ONCOLOGY REPORTS. 2026; Vol. 55, Issue 5, pp. -. DOI: 10.3892/or.2026.9106

10
Mechanistic insights into the roles of astragalosides and Astragalus polysaccharides in gynecological and breast cancers (Review

Author:Liu, Ruixin; Lin, Zhanyu; Li, Yuelin; Ci, Yuetong; Guo, Zhengqi; Xu, Zhenguo

Journal: ONCOLOGY REPORTS. 2026; Vol. 55, Issue 5, pp. -. DOI: 10.3892/or.2026.9102


在线咨询

Oncology Reports

国际简称:ONCOL REP参考译名:肿瘤学报告

年发文量:118 CiteScore:7.7 是否预警:否 Gold OA文章占比:84.52% 研究类文章占比:58.47%

杂志社联系方式:SPANDIDOS PUBL LTD, POB 18179, ATHENS, GREECE, 116 10

Oncology Reports